ImprimisRx NJ: Drug Recall
Recall #D-0060-2023 · 11/09/2022
Class II: Risk
Recall Details
- Recall Number
- D-0060-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- ImprimisRx NJ
- Status
- Terminated
- Date Initiated
- 11/09/2022
- Location
- Ledgewood, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 960 bottles
Reason for Recall
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Product Description
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Distribution Pattern
Nationwide in the USA
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.